|
1
|
Ginès P, Càrdenas A, Arroyo V and Rodès J:
Management of cirrhosis and ascites. N Engl J Med. 350:1646–1654.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pan CX, Tang J, Wang XY, Wu FR, Ge JF and
Chen FH: Role of interleukin-22 in liver diseases. Inflamm Res.
63:519–525. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Puche JE, Saiman Y and Friedman SL:
Hepatic stellate cells and liver fibrosis. Compr Physiol.
3:1473–1492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee UE and Friedman SL: Mechanisms of
hepatic fibrogenesis. Best Pract Res Clin Gastroenterol.
25:195–206. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hernandez-Gea V and Friedman SL:
Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sonnenberg GF, Fouser LA and Artis D:
Border patrol: Regulation of immunity, inflammation and tissue
homeostasis at barrier surfaces by IL-22. Nat Immunol. 12:383–390.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zenewicz LA and Flavell RA: Recent
advances in IL-22 biology. Int Immunol. 23:159–163. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sertorio M, Hou X, Carmo RF, Dessein H,
Cabantous S, Abdelwahed M, Romano A, Albuquerque F, Vasconcelos L,
Carmo T, et al: IL-22 and IL-22 binding protein (IL-22BP) regulate
fibrosis and cirrhosis in hepatitis C virus and schistosome
infections. Hepatology. 61:1321–1331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carmo RF, Cavalcanti MS and Moura P: Role
of interleukin-22 in chronic liver injury. Cytokine. 98:107–144.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang YM, Liu ZR, Cui ZL, Yang C, Yang L,
Li Y and Shen ZY: Interleukin-22 contributes to liver regeneration
in mice with concanavalin A-induced hepatitis after hepatectomy.
World J Gastroenterol. 22:2081–2091. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kong X, Feng D, Wang H, Hong F, Bertola A,
Wang FS and Gao B: Interleukin-22 induces hepatic stellate cell
senescence and restricts liver fibrosis in mice. Hepatology.
56:1150–1159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bolòs V, Grego-Bessa J and de la Pompa JL:
Notch signaling in development and cancer. Endocr Rev. 28:339–363.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nichols AM, Pan Y, Herreman A, Hadland BK,
De Strooper B, Kopan R and Huppert SS: Notch pathway is dispensable
for adipocyte specification. Genesis. 40:40–44. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu T, Hu B, Choi YY, Chung M, Ullenbruch
M, Yu H, Lowe JB and Phan SH: Notch1 signaling in FIZZ1 induction
of myofibroblast differentiation. Am J Pathol. 174:1745–1755. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bielesz B, Sirin Y, Si H, Niranjan T,
Gruenwald A, Ahn S, Kato H, Pullman J, Gessler M, Haase VH and
Susztak K: Epithelial Notch signaling regulates interstitial
fibrosis development in the kidneys of mice and humans. J Clin
Invest. 120:4040–4054. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bansal R, van Baarlen J, Storm G and
Prakash J: The interplay of the Notch signaling in hepatic stellate
cells and macrophages determines the fate of liver fibrogenesis.
Sci Rep. 5:182722015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Trehanpati N, Shrivastav S, Shivakumar B,
Khosla R, Bhardwaj S, Chaturvedi J, Sukriti, Kumar B, Bose S, Mani
Tripathi D, et al: Analysis of Notch and TGF-β signaling expression
in different stages of disease progression during hepatitis B virus
infection. Clin Transl Gastroenterol. 3:e232012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu DH, Guo XY, Qin SY, Luo W, Huang XL,
Chen M, Wang JX, Ma SJ, Yang XW and Jiang HX: Interleukin-22
ameliorates liver fibrogenesis by attenuating hepatic stellate cell
activation and downregulating the levels of inflammatory cytokines.
World J Gastroenterol. 21:1531–1545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen YX, Weng ZH and Zhang SL: Notch3
regulates the activation of hepatic stellate cells. World J
Gastroenterol. 18:1397–1403. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Geisler F and Strazzabosco M: Emerging
roles of Notch signaling in liver disease. Hepatology. 61:382–392.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Y, Zheng S, Qi D, Zheng S, Guo J,
Zhang S and Weng Z: Inhibition of Notch signaling by a γ-secretase
inhibitor attenuates hepatic fibrosis in rats. PLoS One.
7:e465122012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei X, Wang JP, Hao CQ, Yang XF, Wang LX,
Huang CX, Bai XF, Lian JQ and Zhang Y: Notch signaling contributes
to liver inflammation by regulation of interleukin-22-producing
cells in hepatitis B virus infection. Front Cell Infect Microbiol.
6:1322016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu F, Li T, Qiu F, Fan J, Zhou Q, Ding X,
Nie J and Yu X: Preventive effect of Notch signaling inhibition by
a gamma-secretase inhibitor on peritoneal dialysis fluid-induced
peritoneal fibrosis in rats. Am J Pathol. 176:650–659. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mühl H: STAT3, a key parameter of
cytokine-driven tissue protection during sterile inflammation-the
case of experimental acetaminophen (Paracetamol)-induced liver
damage. Front Immunol. 7:1632016. View Article : Google Scholar : PubMed/NCBI
|
